Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Antimicrobial Effect of Casein Phosphopeptide Amorphous Calcium Phosphate on Streptococcus Mutans in Children

NCT03526315 is registered in ClinicalTrials.gov with Jordan University of Science and Technology as lead sponsor.

NCT NCT03526315
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03526315 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Antimicrobial Effect of Casein Phosphopeptide Amorphous Calcium Phosphate on Streptococcus Mutans in Children
Lead sponsor
Jordan University of Science and Technology
Phase
Not applicable
Overall status
Completed
Start date
March 31, 2016
Completion date
October 31, 2016
Enrollment
127 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mutans streptococci, oral health